Bella Weight Loss Capsules
$125.00
$125.000% offBella Weight Loss Capsules
Quantity
Break Through Weight Loss Plateaus Break through weight loss plateaus with Bella, the revolutionary solution designed to reignite progress when results stalled with GLP-1s alone. Bella has consistently helped patients overcome plateaus and achieve dramatic transformations, even when other treatments and companies failed.
Available by prescription only, Bella is an affordable option for any budget and can be taken as a standalone treatment or in combination with GLP-1 medications. With eight unique formulations tailored to individual needs, Bella allows patients and physicians to collaborate on selecting the safest and most effective version during a telemedicine consultation. Whether you’re looking to enhance your current regimen or need a powerful standalone solution, Bella Capsules are the ultimate key to unlocking your weight loss potential.
Compounded semaglutide (compounded GLP-1) can be a medication prescribed for weight loss. It contains the same active ingredient as the groundbreaking medications Wegovy® and Ozempic®.
Compounded GLP-I medications work by mimicking hormones that regulate appetite and digestion — potentially leading to weight loss when combined with diet and exercise.
Compounded semaglutide is customized uniquely for each individual by a state licensed compounding pharmacy. Once prescribed by one of GOAL.MD’s network of licensed healthcare professionals, compounded semaglutide is self-injected just once a week.
At GOAL.MD, we source compounded semaglutide from accredited 503a compounding pharmacies that have a reputation for safety. However, like any medication, there may be side effects. These are usually mild and go away within a couple of weeks.
GOAL.MD’s personalized weight loss solutions are focused on you. Access to injectable (compounded) semaglutide is sourced from audited and licensed US-based compounding pharmacies. It is always available in a customized dosage catered to your specific needs. We also offer a free initial consultation with a network healthcare provider, consistent pricing regardless of dose, and 24/7 access to online support.
Compounded Tirzepatide (compounded GLP-1) is a medication that may be prescribed for weight loss. It combines innovative active ingredients targeting both GLP-1 and GIP receptors, similar to groundbreaking treatments like Zepbound® and Mounjaro®, promoting enhanced and more effective weight loss outcomes.Compounded GLP-1 medications, including Tirzepatide, work by mimicking hormones that regulate appetite and digestion. When combined with a balanced diet and exercise, this mechanism can lead to significant weight loss.Each compounded Tirzepatide treatment is uniquely customized for the individual by a state-licensed compounding pharmacy. Once prescribed by one of GOAL.MD’s network of licensed healthcare professionals, compounded Tirzepatide is self-administered as a simple, once-weekly injection.
At GOAL MD, we source compounded Tirzepatide from accredited 503a compounding pharmacies that have a reputation for safety. However, like any medication, there may be side effects. These are usually mild and go away within a couple of weeks. See more safety information here.
GOAL.MD's personalized weight loss solutions are focused on you. Access to injectable (compounded) tirzepatide is sourced from audited and licensed US-based compounding pharmacies. It is always available in a customized dosage catered to your specific needs. We also offer a free initial consultation with a network healthcare provider, consistent pricing regardless of dose, and 24/7 access to online support.
*After 68 weeks, participants administering once-weekly semaglutide treatment experienced an average of 15% reduction in body weight. The mean change in body weight from baseline to week 68 was −14.9% in the semaglutide group as compared with −2.4% with placebo. (Source)
*A study found GLP-1 RAs to be associated with a significant 12-14% reduction in major adverse cardiovascular events (Source)
*After 68 weeks, participants administering once-weekly semaglutide treatment (combined with diet and exercise) experienced an average of 14.9% reduction in body weight, compared with 2.4% for the placebo. (Source)
**Weight loss based on self reported data from 160 Goal members while on GLP-1 injections, while combined with diet and exercise.
*A study found GLP-1 RAs to be associated with a significant 12-14% reduction in major adverse cardiovascular events (Source)
*After 68 weeks, participants administering once-weekly semaglutide treatment (combined with diet and exercise) experienced an average of 14.9% reduction in body weight, compared with 2.4% for the placebo. (Source)
**Weight loss based on self reported data from 160 Goal members while on GLP-1 injections, while combined with diet and exercise.
clinically tested
Our pharmacies perform third party testing through FDA and DEA registered labs to run quality control checks for every compounded lot prescribed for Goal patients. They test four key characteristics that are associated with quality and safety.
clinically tested
Our pharmacies perform third party testing through FDA and DEA registered labs to run quality control checks for every compounded lot prescribed for Goal patients. They test four key characteristics that are associated with quality and safety.
* Cardiovascular Disease Risk Factors: Improvement in triglycerides and systolic blood pressure begins with 2-5% weight loss. For diastolic blood pressure and HDL cholesterol, improvement begins at 5-10% weight loss. (Source)
Emotional Health: Pursuing dietary interventions for obese patients with comorbid depression could have the additional benefit of relieving some of their depressive symptoms as well as improving their metabolic profile and cardiovascular risk. (Source)
Weight Loss: After 68 weeks, participants administering once-weekly semaglutide treatment experienced an average of 14.9% reduction in body weight, compared with 2.4% for the placebo. (Source)
Find answers to commonly asked questions about GOAL.MD and our GLP-1 treatment plans.
No, We are designed specifically for those who are not covered by insurance.
No, We are unable to accept Medicaid or Anthem, but we do offer affordable monthly payments and financing through CareCredit.
Yes, both are accepted.
Yes, all major credit cards are accepted.
Patients can finance their treatment via Affirm, Klarna, and Care Credit
Some patients choose to stop taking Semaglutide when they reach their goal weight, but we do offer an optional continued service called “Maintenance Mode”. While in maintenance mode your dosage is reduced back to a point where you are neither losing or gaining weight. This continued support is a wonderful option for those concerned about regaining weight.
Yes, This program includes everything required including the semaglutide medication mailed to your home as well as continued care from your dedicated physician.
The most common side effects are nausea, diarrhea, vomiting, constipation, stomach pain, headache, fatigue, dizziness, bloating, gas, and heartburn. More serious side effects may include pancratitis, gallbladder problems, kidney problems, serious allergic reactions, increased heart rate and depression.
Yes, but you may feel full more quickly and many have reported a sharp decreased desire to consume alchohol while taking semaglutide.
Yes, Switching from another provider over to GOAL.MD is easy. Press the get started button, complete the new patient intake form and get scheduled. We will evaluate your progress and dosage, make adjustments and get you back on track.
Copyright 2025. GOAL MD. All Rights Reserved.